1. Ashok PW, Flett GM, Templeton A. Termination of pregnancy at 9-13 weeks’ amenorrhea with mifepristone and misoprostol. Lancet 1998; 352:542-3.
2. Ashok PW, Penney CTC, Flett GM, Templeton A. An effective regimen for early medical abortion : a report of 2000 consecutive cases. Human Reproduc 1998; 13 : 2962-2965.
3. Ashok PW, Templeton A, Wagaarachichi, Flett GM. Factors affecting the outcome of early medical abortion : a review of 4132 consecutive cases. Br J Obstet Gynecol 2002; 109 : 1281-1289.
4. Bartley J, Baird DT. A randomized study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy. Br J Obs Gynae 2002; 109: 1290-1294.
5. Bugalho A, Mocumbi S, Faundes A, David E. Termination of pregnancies of <6 weeks gestation with a single dose of 800 µg of vaginal misoprostol. Contraception 2000; 61 : 47-70.
6. Camerson ST, Glasier AF, Logan J et al. Impact of the introduction of new medical methods on therapeutic abortions at Royal Infirmary of Edinburgh. Br J Obset Gynecol 1996; 103 : 1222-1229.
7. Carbonell JL, Varela L, Velazco A, Ferandez C. These of Misoprostol for Termination of Early Pregnancy. Contraception 1997; 55: 165-168.
8. Carbonell JL, Rodriguez J, Aragon S, Verazco A, Tanda R, Sanchez C, Barambio S, Chani S, Valeco F – Vaginal misoprostol 100 microgram for early abortion – Contraception 2001, 63(3) : 131-6.
9. Carbonell JL, Varela L, Velazco A, Fernandez C. The use of misoprostol for termination of early pregnancy. Contraception 1997; 55 : 165-168.
10. Carbonell JL, Varela L, Velazco A, Fernandez C, Sanchez C. The use of misoprostol for abortion at or < 9 wks gestation. Eur J Contraception Reproduc Health Care 1997; 3 : 181-185.
11. Carbonell Esteve JL, Varela L, Velazco A, Cabezas E, Tanda R, Sanchez C. Vaginal Misoprostol for late first trimester abortion. Contraception 1998; 57 : 329-333.
12. Carbonell Esteve JLL, Varela L, Velazco A, Tanda R, Cabezas E, Sanchez C. Early abortion with 800 µg of Misoprostol by the Vaginal route. Contraception 1999; 59 : 219-225.
13. Carbonell J, Varela L, Velazco A, Tanda S, Sanchez C, B arambio, Chanu S, Valero F, Aragon S, Mari J – Misoprostol for abortion at 9-12 wks gestation in adolescents – Eur J contraception and Reprod Helath Care 2001; 6(1) : 39-48.
14. Coyaji K, et al. Mifepristone-misoprostol abortion : a trial in rural and urban Maharastra, Indian. Contraception 2002; 66 : 33-40.
15. Coyaji K et al. Early Medical Abortion in India : Three studies andtheir implication for abortion services. JAMWA 2000; 55 : 191-194.
16. Creinin MD, Aubney E. Medical abortion in early pregnancy. In : Paul M, Lichtenberg ES, Borgatta L, Grimes DA, Stubblefield PG, editors. A clinicians guide to medical and surgical abortion. New York Churchill Livingstone; 1999. P 91-106.
17. Creinin MD, Shulman T. Effect of nonsteroidal anti inflammatory drugs on action of misoprostol in a regimen for early abortion. Contraception 1997; 56 : 165-8.
18. Creinin MD, Spitz IM. Use of various ultrasonographic criteria to evaluate the efficacy of mifepristone and misoprostol for medical abortion. Am J Obstet Gynaecol 1999; 181 : 1419-24.
19. David T. Baird. Mode of Action of Medical Methods of Abortion. JAMWA 2000; 55 : 121-126.
20. EI-Rafaey H, Rajasekar D, Abdella M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J med 1995; 332 : 983-7.
21. Elul B et al. Can women in less developed countries use a simplified medical abortion regime? Lancet. 2001; 357 : 1402-1405.
22. Fielding SL, Schaff EA, Nam Na-Yon. Clinician’s perception of sonogram indication for mifepristone abortion upto 63 days. Contraception 2002; 66 : 27-31.
23. Ganzalez CH, Vargas FR, Perez AB, Kim CA, Brunoni D, Marques – Dias MJ, et al. Limb deficiency with or without
Mobius sequence in seven Brazilian children association with misoprostol use in first trimester of pregnancy. Am J Med Genet 1993; 47 : 59-64.
24. Gemzell-Danielsson K, Oslund E. Termination of second trimester pregnancy with mifepristone and gemeprost. Acta Obstet Gynaecol Scan 2000; 79 : 7022-6.
25. Grimes DA. Medical abortion in early pregnancy : a review of the evidence. Obstet Gynecol 1997; 89-791-6.
26. Harper C, Ellertson C, Winikoff B. Could American women use mifepristone-misoprostol pills safely with less medical supervision. Contraception. 2002, 65 : 133-142.
27. Harper C, Winikoff B, Ellertson C, Coyaji K. Blood loss with mifepristone – misoprostol abortion : measures from a trial in China, Cuba & India. Int JGynecol Obstet 1998; 63 : 39-49.
28. Indian Council of Medical Research, New Delhi- A Task Force Study. A multicentre randomized comparative clinical trial of 200 mg RU486 (mifepristone) single dose followed by either 5 mg 9-methylene PGE2 Gel (meteneprost) or 600 ug oral PGE1- (misoprostol)for termination of early pregnancy within 28 days of missed menstrual period. Contraception 2000; 62 : 125-130.
29. Jain JK, Meckstrotch KR, Mishell DR Jr. Early pregnancy termination with intravaginally administered sodium chloride
solution moistered misoprostol tablets. Historical comparison with miferistone and oral misoprostol. Am J Obstet Gynecol 1999; 181 : 1386-1391.
30. John K. Jain, Daneil R. Mishell. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second trimester pregnancy. The New England Journal of Medicine 1994; 331 : 290293.
31. Kruse B, Poppema S, Creinin MD, Paul M. Management of side effects in medical abortion. Am J Obstet Gynecol 2000; 183 (2) Suppl. : S65-75.
32. Lichtenberg ES, Grimes DA, Paul M, Abortion complications : prevention and management. In : Paul M, Lichtenberg ES, Borgatta L, Grimes DA, Stubblefield PG, editors. A clinicians guide to medical and surgical abortion. New York Churchill Livingstone; 1999. p 197-216.
33. Medical management of abortion. ACOG practice technical bulletin no 26, April 2001.
34. Paul M, Schaff E, Nichols M. The roles of clinical assessment, human chorionic gonadotropin assays, and ultrasonography in medical abortion practice. Am J Obstet Gynaecol 2000; 183 : S35-S43.
35. Peyron R, Dubeny E, Eisinger S, Stadalius L. Early termination with mifepristone and the orally active prostaglandin misoprostol. N Engl J Med 1993; 328 : 1509-1513.
36. Rachel K, Stanley K. Henshaw. Mifepristone for early medical abortion : experiences from France, Great Britain and Sweden. Perspecitves on sexual and reproductive health. 2002, 34(3).
37. Roas Zhou et al. Medical Abortion in China : Results of a Fact-Finding Mission. Population Council. 2002.
38. Royal College of Obstetrics and Gynaecologists. National Evidence based clinical guidance. The care of women requesting induced abortion.
39. Schaff EA, Eisinger SH Stadilius LS, Frank P Gore BZ, Peppema S. Low dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1996; 59 : 1-6.
40. Schaff EA, Fielding SL, Eisinger S, Stadalius L. Mifepristone and misoprostol for early abortion when no gestation sac is present. Contraception 2001; 63 : 251-254.
41. Schaff EA, Fielding SL, Eisinger SH, Stadalins LS, Fuller L. Low dose mifepristone followed by vaginal misoprostol at 48 hours for abortion upto 63 days. Contraception 2000; 5 : 41-46.
42. Scheepers CJ, van Erp EJM, van den Berg AS. Use of Misoprostol in first and second trimester abortion : a review. CME Review Article 1999; 54 : 592-600.
43. Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998; 338 : 1241-1247.
44. Suzanne R. Trupin, Moreno Carey. Medical Abortion : Overview and Management. Medscape Women’s Health eJournal
45. Tang OS, Thong KJ, Baird DT. Second trimester medical abortion with mifepristone and gemeprost : a review of 956 cases. Contraception 2001; 64 : 29-32.
46. Thong KJ, Dewar MH, Baird DT. What do women want during medical abortion? Contraception 1992; 46 : 435-42.
47. Thong KH, Lynch P, Baird DT. A randomized study of two doses of gemeprost in combination with mifepristone for induction of
abortion in the second trimester of pregnancy. Contraception 1996; 54 : 97-100.
48. Tina B. Koopersmith R, Daniel Mishell Jr. The use of misoprostol for termination of early pregnancy. Contraception 1996; 53 : 237-242.
49. UK Multicentre trial – The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy less than 63 days gestation; UK multicentre study – Final results. Contraception 1997; 55: 1-5.
50. Winikoff B, Ellertson C, Clark S. Analysis of failure in medical abortion. Contraception 1996; 54 : 323-7.
51. World Health Organization Task force on post ovulatory methods of fertility regulation. Comparison of 2 doses of mifepristone with misoprostol for early abortion : a randomized trial. Br J Obstet Gynecol 2000; 107 : 524-530.
52. Wu S. Medical abortion in China. J Am Med Women Aaoc. 2000; 55 : 197-199.
53. Wu Shangchun et al. An Investigation of Mifepristone Use for Medical Abortion in Beijing, Human Guangdong. CHIN J FAM PLAN. 1999, 7(1) : 202-210.
54. Xu J, Chen H, Ma T, Wu X. Termination of early pregnancy in the scarred uterus with mifepristone and misoprostol. IJOG 2001; 72 : 245-251.